業績

Abe N, Kato M, Kono M, Fujieda Y, Ohira H, Tsujino I, Oyama-Manabe N, Oku K, Bohgaki T, Yasuda S, Atsumi T.

Right ventricular dimension index by cardiac magnetic resonance for prognostication in connective tissue diseases and pulmonary hypertension.

Rheumatology (Oxford). 2019

PMID: 31424519

  • 2019
  • 膠原病グループ
  • 欧文論文/著書

Efthymiou M, Mackie IJ, Lane PJ, Andrade D, Willis R, Erkan D, Sciascia S, Krillis S, Bison E, Borges Galhardo Vendramini M, Romay-Penabad Z, Qi M, Tektonidou M, Ugarte A, Chighizola C, Belmont HM, Aguirre MA, Ji L, Branch DW, de Jesus G, Fortin PR, Andreoli L, Petri M, Cervera R, Rodriguez E, Knight JS, Atsumi T, Vega J, Ecem S, Bertolaccini ML, Pengo V, Cohen H; APS ACTION.

Comparison of Real World and Core Laboratory Lupus Anticoagulant Results from the Antiphospholipid Syndrome (APS) ACTION Clinical Database and Repository.

J Thromb Haemost. 2019 Jul 30. 

PMID: 31364274

  • 2019
  • 膠原病グループ
  • 欧文論文/著書

Ninagawa K, Kato M, Nakamura H, Abe N, Kono M, Fujieda Y, Oku K, Yasuda S, Ohira H, Tsujino I, Atsumi T.

Reduced diffusing capacity for carbon monoxide predicts borderline pulmonary arterial pressure in patients with systemic sclerosis.

Rheumatol Int. 2019 

PMID: 31280357

 

  • 2019
  • 膠原病グループ
  • 欧文論文/著書

Radin M, Sciascia S, Erkan D, Pengo V, Tektonidou MG, Ugarte A, Meroni P, Ji L, Belmont HM, Cohen H, Ramires de Jesús G, Branch DW, Fortin PR, Andreoli L, Petri M, Rodriguez E, Rodriguez-Pinto I, Knight JS, Atsumi T, Willis R, Gonzalez E, Lopez-Pedrera R, Rossi Gandara AP, Borges Gualhardo Vendramini M, Banzato A, Sevim E, Barbhaiya M, Efthymiou M, Mackie I, Bertolaccini ML, Andrade D; APS ACTION.

The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.

Semin Arthritis Rheum. 2019 

PMID: 31153708

  • 2019
  • 膠原病グループ
  • 欧文論文/著書

Abe N, Kato M, Fujieda Y, Narita H, Tha KK, Atsumi T.

Tumour necrosis factor alpha blockade for non-inflammatory pain: beyond inflammation?

Scand J Rheumatol. 2019

PMID: 31135248

  • 2019
  • 膠原病グループ
  • 欧文論文/症例報告

Yajima N, Tsujimoto Y, Fukuma S, Sada KE, Shimizu S, Niihata K, Takahashi R, Asano Y, Azuma T, Kameda H, Kuwana M, Kohsaka H, Sugiura-Ogasawara M, Suzuki K, Takeuchi T, Tanaka Y, Tamura N, Matsui T, Mimori T, Fukuhara S, Atsumi T.

The development of quality indicators for systemic lupus erythematosus using electronic health data: A modified RAND appropriateness method.

Mod Rheumatol. 2019 (PMID:31111758)

  • 2019
  • 膠原病グループ
  • 欧文論文/著書

Montemurro C*, Nomoto H*, Pei L*, Vongbunyong KE, Vadrevu S, Gurlo T, Butler AE, Subramaniam R, Ritou E, Shirihai OS, Satin LS, Butler PC, Tudzarova S. IAPP toxicity activates HIF1α/PFKFB3 signaling delaying β-cell loss at the expense of β-cell function. Nat Commun. 2019. PMID: 31213603 (*: joint first authors)

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Sekizaki T, Kameda H, Oba C, Cho KY, Nakamura A, Miyoshi H, Osawa T, Shinohara N, Atsumi T. Nivolumab-induced hypophysitis causing secondary adrenal insufficiency after transient ACTH elevation. Endocr J, in press

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/症例報告

Miya A, Nakamura A, Kameda H, Nozu K, Miyoshi H, Atsumi T. Gitelman’s Syndrome with hyperphosphatemia, effectively responding to single oral magnesium oxide administration: A case report. Medicine, in press

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/症例報告

Miyoshi H, Kameda H, Yamashita K, Nakamura A, Kurihara Y. The protective effect of sodium-glucose cotransporter 2 inhibitors in patients with rapid renal function decline, stage G3 or G4 chronic kidney disease, and type 2 diabetes. J Diabetes Investig in press. (PMID: 31026373)

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著